{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"106"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Total number of AEs observed.","groups":[{"description":"All participants who received at least two cycles of CFZ either at 27mg/m\\^2, 36mg/m\\^2, 45 mg/m\\^2, or 56mg/m\\^2.","id":"OG000","title":"CFZ With Bendamustine and Dexamethasone"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"30 Days Post Last Dose, Up to approximately 9 months","title":"Number of Adverse Events (AEs)","type":"SECONDARY","unitOfMeasure":"Adverse Events"}